InvestLog
DCOY Decoy Therapeutics Inc. logo

DCOY Decoy Therapeutics Inc.

Healthcare
$7.30+13.53%ClosedMarket Cap: $3.9M

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

0.91

P/S

0.00

EV/EBITDA

0.30

DCF Value

$20.40

FCF Yield

-168.3%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

-395.4%

ROA

-154.7%

ROIC

-339.9%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$0.00$-2.2M$—
Q4 null$0.00$-9.0M$—
FY null$0.00$-12.5M$—
Q3 null$0.00$-873.5K$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$—

Target (Median)

$—

Target Range

$— - $—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All
HANISH ARNOLD Cdirector
SellFri Jan 02
HANISH ARNOLD Cdirector
SellFri Jan 02
PIERCE FREDERICK IIofficer: Chief Executive Office
SellMon Nov 24
Marschel Peter Klausofficer: Chief Business Officer
SellMon Nov 24
Marschel Peter Klausofficer: Chief Business Officer
SellMon Nov 24

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

—

Beta

0.38

Decoy Therapeutics, Inc. is a preclinical-stage biotechnology company that is leveraging machine learning and AI tools alongside high-speed synthesis techniques to rapidly design, engineer and manufacture peptide conjugate drug candidates that target serious unmet medical needs. The company is headquartered in Cambridge, MA.

Peers

ATXI logoATXIENVB logoENVBGTBP logoGTBPINDP logoINDPLIPO logoLIPONKGN logoNKGNPBM logoPBMREVB logoREVBSLXN logoSLXNSPRC logoSPRC